• Penicillin G Sodium: Bench Workflows & Troubleshooting

  2026-09-24

  Build a more interpretable antimicrobial workflow with Penicillin G Sodium by pairing fresh-solution handling with controlled susceptibility testing and appropriate resistance controls. A separate intestinal-barrier study offers useful assay-design lessons—but not evidence that this antibiotic protects epithelial barriers.

• Ampicillin Sodium: Assays, Selection & Troubleshooting

  2026-09-24

  Use Ampicillin sodium to investigate bacterial cell wall inhibition, compare antibacterial responses, or maintain ampicillin-selectable expression constructs. This guide connects assay design and practical controls with a classic recombinant-protein workflow, while clarifying where those applications should—and should not—be interpreted together.

• Sodium dicloxacillin monohydrate in MSSA assays

  2026-09-23

  Build paired extracellular and intracellular MSSA assays to see where dicloxacillin activity changes—and why broth MIC alone may not predict the full response. This guide turns published time-kill and PK/PD findings into practical concentration, pH, and sampling choices for research workflows.

• Sulfamonomethoxine Toxicity Across Aquatic Trophic Levels

  2026-09-23

  Huang and colleagues evaluated sulfamonomethoxine toxicity across algae, cladocerans, and medaka, combining acute and chronic bioassays to compare sensitivity among aquatic trophic levels. The study identifies microalgae as especially responsive test organisms and provides a useful framework for interpreting antibiotic risks in aquaculture-impacted waters.

• Caprine Mastitis Pathogens and Gamithromycin

  2026-09-22

  A 2022 study compared gamithromycin with tildipirosin, oxytetracycline, and danofloxacin against caprine mastitis isolates under standard and goat-serum-supplemented conditions. Its central finding is that serum substantially changes the apparent potency of macrolides, showing why susceptibility testing should better approximate the biological environment of infection.

• Calpain Inhibitor I, ALLN: Practical Workflow

  2026-09-22

  Calpain Inhibitor I, ALLN (SKU A2602) is a water-insoluble cysteine-protease inhibitor for controlled studies of calpain and cathepsin activity in apoptosis assays, inflammation research, and ischemia-reperfusion injury models. It should be prepared in DMSO or ethanol with matched vehicle controls and should not be treated as a validated clinical, diagnostic, or aqueous-only reagent.

• Geneticin: G418 Sulfate Selection Workflows

  2026-09-21

  Geneticin, G418 Sulfate, supports reproducible stable-cell selection while also enabling carefully controlled antiviral assays. This guide connects kill-curve design, neomycin-resistance workflows, Dengue virus testing, and MRE11 mutation-model development with practical troubleshooting boundaries.

• Hexetidine (NSC-17764) Oral Antimicrobial Workflows

  2026-09-21

  Hexetidine (NSC-17764) supports reproducible planktonic, biofilm, and surface-challenge experiments spanning oral bacteria and Candida albicans. This workflow emphasizes matrix effects, solvent control, adsorption behavior, and clinically relevant exposure conditions rather than relying on a single MIC value.

• Ertapenem Sodium Salt for Resistance Research

  2026-09-20

  Ertapenem sodium salt supports a connected workflow from MIC profiling to carbapenemase-gene transmission studies. This guide shows how to use its broad antibacterial activity, formulation properties, and phenotype–genotype comparisons to build more interpretable antibiotic resistance assays.

• Vancomycin Workflows for MRSA Resistance Research

  2026-09-19

  Build reproducible Vancomycin susceptibility, resistance, and microbiome workflows around validated broth microdilution principles. Practical guidance covers DMSO handling, MRSA assay design, comparative antibiotic testing, and troubleshooting for reliable results.

• Sodium Dicloxacillin in Intracellular MSSA Research

  2026-09-18

  A translational framework for using sodium dicloxacillin monohydrate to connect PBP-directed mechanism, intracellular MSSA activity, pH-dependent potency, and free-drug PK/PD design.

• Shufeng Xingbi Therapy in Allergic Rhinitis Rats

  2026-09-18

  A bioRxiv preprint evaluates Shufeng Xingbi Therapy in an ovalbumin-induced rat model of allergic rhinitis, combining nasal immunology, histopathology, serum biomarkers, and 16S rDNA profiling. The findings associate treatment with reduced allergic inflammation, altered gut microbial composition, increased short-chain fatty acids, and suppression of selected Th2-related signaling markers, while leaving causal and translational questions open.

• ROR1 Signaling: From Cancer Biology to Liver Models

  2026-09-17

  A translational framework for using Anti-ROR1 Antibody (Zilovertamab) to investigate Wnt5a signaling, tumor biology, and emerging liver injury hypotheses without overstating the evidence.

• Hexetidine (NSC-17764): From Rinse to Rigor

  2026-09-17

  Hexetidine (NSC-17764) is best understood as a phenotypic, broad-spectrum antimicrobial rather than a single-target inhibitor. This thought-leadership guide connects membrane-level biology, biofilm assay design, oral translation, and the important boundary between antimicrobial activity and antiviral protease inhibition.

• X-press Tag Peptide for RHEB Assays

  2026-09-16

  Build cleaner recombinant RHEB workflows with an N-terminal leader peptide that supports ProBond capture, Anti-Xpress antibody detection, and optional enterokinase removal. This guide connects practical purification decisions with the UBE2F-SAG-RHEB findings while clearly separating assay utility from biological proof.

8009 records 1/534 page Next 12345 下5页 Last page